Foveal Thickness Fluctuation in Anti-VEGF Treatment for Branch Retinal Vein Occlusion: A Long-term Study.

Abstract

PURPOSE:

Branch retinal vein occlusion (BRVO) causes macular edema (ME), which can be controlled with anti-VEGF treatments. However, these treatments are not curative, necessitating additional anti-VEGF treatments at recurrence. Long-term results, optimal anti-VEGF treatment regimens, and the comprehensive effects of ME recurrence are largely unknown. Thus, we aimed to examine the effects of foveal thickness (FT) fluctuation (FTF) on the visual and morphologic outcomes of anti-VEGF treatments for BRVO-ME administered via a pro re nata regimen.

DESIGN:

A retrospective, observational case series.

SUBJECTS:

This study analyzed 309 treatment-naïve patients (309 eyes) with BRVO-ME between 2012 and 2021 at a multicenter retinal practice.

METHODS:

The FT was assessed using OCT at each study visit.

MAIN OUTCOME MEASURES:

We evaluated the logarithm of the minimal angle of resolution (logMAR) best corrected visual acuity (BCVA) and the defect length of the foveal ellipsoid zone (EZ) band using OCT.

RESULTS:

At baseline, the mean logMAR BCVA was 0.30 ± 0.30 and the mean FT was 503 ± 162 μm. The number of anti-VEGF injections for BRVO-ME was 5.8 ± 4.6 during the mean follow-up period (50.6 ± 22.2 months). At the final examination, the mean logMAR BCVA and FT values were significantly improved compared with those at the baseline. Multiple regression analyses showed that age, baseline logMAR BCVA, and FTF were significantly associated with the final logMAR BCVA (β = 0.20, 0.35, and 0.30, respectively). Foveal thickness fluctuation (divided into groups 0-3 in ascending order of FTF) was significantly associated with logMAR BCVA and the defect length of the foveal EZ band at the final examination. The defect lengths of the foveal EZ band were longitudinally shortened in groups 0 and 1 and were slightly prolonged in groups 2 and 3. The logMAR BCVA showed improvements in groups 0 and 1 and worsened slightly in groups 2 and 3.

CONCLUSIONS:

Foveal thickness fluctuation was significantly associated with visual acuity and foveal photoreceptor status. Thus, the morphologic and functional prognoses of eyes with BRVO may improve with the identification of the characteristics of eyes with greater FTF and consequently controlling the FTF more strictly.

• Authors: Daisuke Nagasato, Yuki Muraoka, Mao Tanabe, Naomi Nishigori, Rie Osaka, Yoshinori Mitamura, Hitoshi Tabuchi, Shin Kadomoto, Tomoaki Murakami, Sotaro Ooto, Kiyoshi Suzuma, Akitaka Tsujikawa
• Journal: Ophthalmology. Retina (Ophthalmol Retina) Vol. 6 Issue 7 Pg. 567-574 (07 2022) ISSN: 2468-6530 [Electronic] United States
• PMID: 35218996 (Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Chemical References

• Angiogenesis Inhibitors
• Vascular Endothelial Growth Factors

Topics

• Angiogenesis Inhibitors (therapeutic use)
• Fovea Centralis
• Humans
• Macular Edema (diagnosis, drug therapy, etiology)
• Retinal Vein Occlusion (complications, diagnosis, drug therapy)
• Retrospective Studies
• Vascular Endothelial Growth Factors